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1ABSTRACT
The role of CIIA gene in cellular reprogramming
Eunhyun Ji
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Dong-Wook Kim)
Terminally differentiated cells are known to be reprogrammed into induced 
pluripotent stem cells (iPSCs) when Yamanaka factors (Oct4, Sox2, klf4 and cmyc; 
OSKM) are introduced.  In recent years, iPSC technology has been applied to 
improve the efficiency and safety of clinical applications. This study demonstrates 
that knockdown of the CIIA gene (a caspase-activated DNase inhibitor that interacts 
with ASK1) can enhance reprogramming efficiency in human fibroblasts. Short-
term repression of CIIA by siRNA transfection in fibroblasts reduced epithelial-
mesenchymal transition (EMT) in the early stage of reprogramming. On the other 
hand, prolonged suppression of CIIA through shRNA knocking-down induced 
epigenetic modifiers and pluripotent genes in the late stage of cellular 
reprogramming. At the transcriptional level, CIIA also acts as an inhibitory 
influence on the reprogramming process through a histone modification factor, Sirt1. 
In addition, fibroblasts via knocking-down of CIIA and transfection of OSKM 
produced greater numbers of embryonic stem cell (ESC)–like colonies, compared 
with those with OSKM transfection alone. Collectively, these results show that the 
2CIIA gene plays a role in cell fate change and provide a new mechanistic 
framework to better understand the effects of CIIA in cellular reprogramming.
Key words: induced pluripotent stem cells, CIIA, EMT, epigenetic modification, 
cellular reprogramming
3The role of CIIA gene in cellular reprogramming
Eunhyun Ji
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Dong-Wook Kim)
I. INTRODUCTION
Differentiated cells can be reprogrammed into an embryonic stem cell 
(ESC)–like state by specific transcription factors, originally designated as Oct4, 
Sox2, klf4, and cMyc (OSKM).1,2 These reprogrammed cells, called induced 
pluripotent stem cells (iPSCs), are promising cell sources for cellular therapy and 
disease modeling.3 The reason for this is that, compared with the use of ESCs, the 
use of iPSCs for therapeutic applications both avoids the ethical concerns of using 
embryos and solves the immune rejection problem by using patient-specific iPSCs 
that already match the patient’s own system.4,5 However, in spite of the rapid 
advance of iPSC technology, the challenges that still remain are low reprogramming 
efficiencies and the extended time required when reprogramming.6,7 Thus, extensive 
knowledge of the reprogramming mechanism has been reported in order to obtain 
iPSCs more efficiently. In previous studies, two critical changes have been 
primarily considered: a mesenchymal-to-epithelial transition (MET)8 and an 
epigenetic modification.9,10 In the early stage, an MET, the process of switching cell 
fate, is required for cellular reprogramming. Therefore, discovering inhibitors of 
EMT or MET inducers was one of previous strategies.8,11-13 In the late stage, 
4reprogramming intermediates undergo widespread epigenetic changes, including 
DNA methylation and histone modification, that are essential for the conversion of 
somatic cells to fully reprogrammed iPSCs.9,10,14,15 Researchers also continue to 
uncover epigenetic modifiers that induce cellular reprogramming.16-19
Despite these efforts, few somatic cells form bona fide iPSC colonies:
14,17,18,20 the rest of the cells, on the other hand, fail to be fully reprogrammed 
because barriers interfere with the overall flow of reprogramming, including those 
two major cellular modifications. Therefore, this study has aimed to identify a factor 
that regulates those two changes during cellular reprogramming. In examining 
cellular and molecular changes during reprogramming, I noticed that this is 
extremely similar to the circumstance of down-regulation of CIIA expression in 
somatic cells. CIIA was initially discovered as an anti-apoptotic protein21 that 
proved to be identical to VPS28. Aside from these initial studies on the role of CIIA, 
previous studies have reported that caspase activity is regulated by the expression of 
CIIA.22 Furthermore, subsequent studies have shown that CIIA induces EMT via 
down-regulation of claudin-1 and is involved in TGF-β-induced migration, which is 
a representative EMT feature.23 Given earlier studies about the function of CIIA, I 
hypothesized that CIIA potentially plays a significant role in cell fate determination 
as well as cell survival.
This study discovered that CIIA is a barrier to the conversion of bona fide
iPSCs. Suppressed CIIA expression affects reprogramming to iPSCs, showing the 
change of EMT genes and epigenetic modifiers. Moreover, Sirt1, as one of the 
epigenetic modifiers, which was known as a regulator of histone modification or 
DNA methylation, was especially observed with increased expression in CIIA 
down-regulated human fibroblasts. Combining OSKM induction with CIIA 
inhibition in human fibroblasts revealed enhanced reprogramming efficiency. In 
addition to this, this study identified a molecular mechanism underlying the CIIA-
Sirt axis in the early and late stages of reprogramming. This mechanism also opened 
5epigenetic marks of key reprogramming factors. These results suggest that the 
CIIA-Sirt regulatory axis is a specific point of concern during reprogramming.
6II. MATERIALS AND METHODS
1. Culture of human ES cells
Human ES cell line, H9 (p37-49, WiCell Inc., Madison, Wisconsin, USA) 
was routinely cultured in Knockout-Serum Replacement (KSR) medium containing 
Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Invitrogen, Carlsbad, CA, 
USA) supplemented with 20% KSR (Invitrogen), 1X nonessential amino acid 
(Invitrogen), 0.1 mM beta-mercaptoethanol (Sigma, St. Louis, MO, USA), and 4 
ng/ml of basic fibroblast growth factor (bFGF) (Invitrogen) on the layer of 
mitomycin-C (Sigma) treated mouse STO feeder cells (ATCC, Manassas, VA, USA). 
Human ES cell colonies were transferred onto the fresh feeder cells weekly by 
mechanical passaging. 
2. Culture of fibroblasts
BJ human fibroblasts (ATCC, Manassas, VA, USA) were cultured in MEM 
with 10% FBS and 1% Glutamax. 293T cells (Invitrogen) were cultured in DMEM 
supplemented with FBS (10% vol/vol) and antibiotics (1%).
3. siRNA transfection
Two days prior to electroporation BJ human fibroblasts or human ES cells 
were plated onto 60mm culture plates. The next day cells were electroporated with 
the Neon™ transfection system (Invitrogen) according to the manufacturer’s 
instructions. In each electroporation reaction, cells were electroporated with 100uM 
control siRNA or CIIA siRNA (sense CCU GGG AAC AAG CCG GAG CUG
UAU GAG GAU U, antisense UCC UCA UAC AGC UCC GGC UUG UUC
CCA GGU U). The conditions used for electroporation were 1150 V pulse voltage, 
20 ms pulse width and three pulses for BJ fibroblasts and 1100 V pulse voltage, 30 
7ms pulse width and one pulse for hESCs. After the electroporation, each reaction 
was plated onto new 60mm culture plates containing BJ fibroblast or hESC medium.
4. Lentiviral production and shRNA transduction
shRNA fragments were obtained from Origene (Plasmid TL300557: 
pGFP-C-Lenti puro shCIIA, Rockville, MD, USA). shRNA fragments were 
obtained from Origene (Plasmid TL300557: pGFP-C-Lenti puro shCIIA, Rockville, 
MD, USA). Vectors were produced by transient transfection in 293FT cells. The day 
before transfection, plate 293FT cells in a 10 mm culture plate so that they would be 
70–75% confluent on the day of transfection. On the day of transfection, remove the 
culture medium from the 293FT cells and replace with 7ml of growth medium 
(without antibiotics). For each transfection sample, 5 μg of the virus construct were 
mixed with 1 μg of the VSV-G envelope plasmid (pLP/VSVG, Invitrogen) and 4 μg 
of the packaging plasmid (pLP1 and pLP2, Invitrogen). The solution was adjusted 
to 200 μl with Opti-MEM® (Invitrogen) and mixed with 10 μl of 1 mg/ml 
polyethyleneimine (PEI, Sigma). The mixture of DNA and solution incubate for 15 
minutes at room temperature. Add the mixture dropwise to each plate of cells. Mix 
gently by rocking the plate back and forth. Incubate the cells overnight at 37 °C in a 
humidified 5 % CO2 incubator. The next day, remove the medium containing the 
DNA and PEI solution and replace with 10 ml complete culture medium without 
antibiotics. Incubate at 37 °C in a humidified 5 % CO2 incubator. Harvest virus-
containing supernatant 72–96 hours post-transfection into a 15 ml conical tube, 
centrifuge briefly (3000rpm for 10 min) and filter through a 0.45 μm filter. Next, 
clarified supernatant transfer to a sterile container and combine 1 volume of 40% 
PEG solution with 3 volumes of clarified supernatant and mix by gentle inversion. 
The mixed supernatants incubate at 4 °C for overnight. The samples centrifuge at 
24,000 rpm for 1h 30minutes at 4 °C. After centrifugation, carefully remove 
supernatant. At last, gently resuspend the pellet in proper volume using phosphate-
8buffered saline (PBS) at 4 °C for overnight. Lentivirus containing KD constructs 
was transduced and stable cell lines were selected by addition of Puro at 1ug/ml on 
day 2 following transduction, continuing for at least 1 week.
5. Lentiviral overexpression
pLVX-tight Puro-GFP based vectors expressing CIIA, or a control empty 
vector were used to generate virus, and transduced as above.
6. Semi-quantitative reverse transcription- and quantitative reverse transcription-
polymerase chain reaction (qRT-PCR) assay
Total RNA was extracted using an Easy-Spin® total RNA purification kit 
(iNtRON Biotechnology, Seoul, Korea) according to the manufacturer’s instructions. 
One microgram of RNA was reverse transcribed to cDNA with iScript cDNA 
Synthesis Kit (Bio-Rad). qRT-PCR was performed using SYBR® Premix Ex TaqTM
(TAKARA BIO Inc., Otsu, Japan) on the CFX96 Real-Time System (Bio-Rad) 
under the following conditions; 1 minute at 95 °C; 32 cycles of 15 seconds at 95 °C, 
20 seconds at 62 °C, 20 seconds at 72 °C; and 15 seconds extension at 95 °C. β-
actin transcript was used as an endogenous reference to calculate Ct values and 
relative expression level (value of 2-ΔΔCt) of target genes according to Bio-Rad’s 
instruction. All treated samples are represented as the expression level of the gene 
relative to their corresponding untreated control (control value equals to one). For 
semi-quantitative RT-PCR, PCR reactions were carried out with 2X EmeraldAmp®
GT PCR Master Mix (TAKARA BIO Inc.) and 10 pM of each primer. Samples 
were amplified in a GeneAmp PCR System 2700 (Applied Biosystems, Carlsbad, 
CA, USA) under the following conditions: denaturing step at 95 °C for 30 seconds, 
annealing step at 60 °C for 30 seconds, and amplification step at 72 °C for 30 
seconds for 20–35 cycles. cDNA templates were normalized based on the GAPDH-
specific signal. The primer sequences are shown in Table1.
9TABLE 1. Primer sequence used in this study
Name Sequence
CIIA
F  ATG TCG GCG TCA GAT GAG
R  CGG TTG AAG GCG TTG TAG
Oct4
F  CCT CAC TTC ACT GCA CTG TA
R  CAG GTT TTC TTT CCC TAG CT
Sox2
F  CCC AGC AGA CTT CAC ATG T
R  CCT CCC ATT TCC CTC GTT TT
Nanog
F  AGC CCC AGC TCC AGT TTC AGC
R  AAT GAT CGT CAC ATA TCT TCA GGC
c-Myc
F  TAT TCT GCC CAT TTG GGG ACA
R  TTG GTG AAG CTA ACG TTG AGG
N-cadherin
F  CCC TGC TTC AGG CGT CTG TA
R  TGC TTG CAT AAT GCG ATT TCA CC
ZEB1
F  ATG CAC AAC CAA GTG CAG AAG AGC
R  TTG CCT GGT TCA GGA GAA GAT GGT
Snail
F  GGA AGC CTA ACT ACA GCG AGC T
R  GCT GGA AGG TAA ACT CTG GAT TAG
TGFβR2
F  TGT TGA GCT CTT CAA GCA GAC CGA
R  ACT TCT CCC ACT GCA TTA CAG CGA
Sirt1
F  TTG GTG AAG CTA ACG TTG AGG
R  TAC AGC AAG GCG AGC ATA
TET1
F  GAA CCA TTG GAT TCA CTC AGC TTA
R  TCA CCG TTA ACT GTA CCT GAG AAT
BRG1(SMACA4)
F  CCT AAC CCA CCC AAC CTC
R  ACT GCT GCT GTC CTT GTA
BAF155(SMARCC1)
F  TGA TAA AGC ACA AGA TGG AGA AA
R  TTG GTA TCC TCA CTC ACT TCA
BAF60A(SMRACD1)
F  GAG CGG GAG TTT GTC ATC
R  CTG GTG GCA TAA GCA AGG
Actin
F  TTG CCG ACA GGA TGC AGA AGG A
R  AGG TGG ACA GCG AGG CCAGGA T
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7. Alkaline Phosphatase staining and Immunocytochemistry
Alkaline phosphatase staining was performed following the manufacturer’s 
recommended procedure (Sigma-Aldrich). Cells were fixed with 4 % 
paraformaldehyde in PBS for 15 minutes, washed with PBS, and perforated with 
PBS containing 0.1 % Triton X-100 for 10 minutes. Then samples were incubated 
with blocking buffer [PBS containing 2 % bovine serum albumin (BSA)] for 1 hour. 
Cells were incubated at 4 °C with primary antibodies diluted in PBS containing 2 % 
BSA for overnight. The following primary antibodies were used: rabbit anti-Oct3/4
(1:200, Santa-Cruz Biotechnology, Santa-Cruz, CA, USA), mouse anti-VPS28
(1:250, Abcam, Cambridge, UK). The samples washed 3 times for 5 minutes with 
PBS and then incubated fluorescent-labeled secondary antibodies [Alexa Fluor 488 
(green) or Alexa fluor 594 (red)-labeled donkey/goat IgG (1:1000; Molecular 
Probes, Invitrogen) in PBS with 2 % BSA for 1 hr at room temperature. The 
coverslips were rinsed for 3 times for 10 minutes each in PBS and mounted onto 
slides using VECTASHIELD Hardset mounting medium with DAPI (Vector 
laboratories, Buringame, CA, USA). Images were obtained under a fluorescence 
microscope ECLIPSE, Ti-U (Nikon, Tokyo, Japan).
8. Chromatin Immunoprecipitation (ChIP) assay
For ChIP assays, 293T cells (Invitrogen) were cultured in DMEM 
supplemented with FBS (10% vol/vol) and antibiotics (1%), at which point the cells 
were fixed with formaldehyde for 10 min, and then 0.125 M glycine was added to 
stop the reaction. The cells were washed twice with PBS. The ChIP assays were 
performed with a ChIP kit commercially obtained from R&D systems according to 
the manufacturer’s instructions. Briefly, the fixed cells were lysed to shear the DNA 
to 200~500 bp. The cross-linked complexes (DNA-protein) were 
immunoprecipitated with anti-H3K4me3 (Active Motif), and normal goat IgG. 
ChIP-enriched DNA was quantified by qRT-PCR, and primer pairs were Oct4 
11
promoter region.
9. Generation and Maintenance of iPSCs
Episomal vectors encoding defined reprogramming factors were used as 
reported.24 In brief, BJ fibroblasts were electroporated by using a microporator 
system (Neon; Invitrogen) with episomal vector mixtures (total 3 μg) according to 
the manufacturer’s instructions. After being pulsed three times with 1150 voltages
for 20 ms, the cells were grown further in BJ medium. Seven days after transfection, 
cells were transferred onto a feeder layer and grown in iPSC medium. iPSC 
colonies that looked similar to hESCs were picked up mechanically and further 
cultured.
10. Statistics
Values were expressed as means ±S.D. Student’s t-test and ANOVA test 
using the Prism 6.0 used to determine statistical significance. 
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III. RESULTS
1. Difference in expression level of CIIA between undifferentiated H9 cells and 
differentiated BJ fibroblasts
The previous findings suggested that tight regulation of CIIA is essential 
for proper embryonic development as well as the growth and function of cells and 
tissues.22,25 In the present study, I hypothesized that CIIA potentially plays an 
important role for cell fate determination. To investigate the role of CIIA in 
undifferentiated H9 cells and differentiated BJ fibroblasts, I performed qRT-PCR 
analysis targeting CIIA. The expression of CIIA was low in H9 hESCs, but BJ 
fibroblasts showed elevated levels of CIIA compared with H9 hESCs. In contrast, 
the expression level of Oct4, an important factor for pluripotency, was 
predominantly expressed in H9 hESCs compared with BJ fibroblasts (Fig. 1A). To 
further examine whether CIIA is a negative regulator in the maintenance of hESCs, 
I investigated its expression in hESCs inducing differentiation with retinoic acid 
(RA) for 4 days.26 qRT-PCR analysis revealed that during spontaneous 
differentiation, CIIA mRNA time-dependently increased for 4 days, while the 
expression of the pluripotency-related genes Oct4, Sox2, and Nanog decreased (Fig. 
1B). Consistently, immunofluorescence staining confirmed elevated expression of 
CIIA and downregulated expression of Oct4 during RA-induced differentiation of 
H9 hESCs (Fig. 1C). To further determine the role of CIIA in hESCs, CIIA-specific 
siRNA to knockdown CIIA mRNA expression was transfected into H9 hESCs. As 
shown via qRT-PCR analysis, knockdown of CIIA expression increased Oct4 
expression in H9 hESCs (Fig. 1D). The results indicate that CIIA is required for the 
differentiation of hESCs and its suppression might play a positive role in cellular 
reprogramming.
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Figure 1. CIIA is required for the differentiation of hESCs in vitro. (A) qRT-PCR 
analysis targeting CIIA and Oct4 in undifferentiated H9 cells and differentiated BJ 
fibroblasts. (B) Time-dependent mRNA expression of pluripotent genes such as 
Oct4, Sox2, and Nanog, as well as CIIA in H9 hESCs after RA treatment for 4 days. 
(C) Immunocytochemical detection of Oct4 and CIIA in H9 cells after treatment 
with or without RA for 4 days. D0 (RA-) is the undifferentiated control. (D) qRT-
PCR analysis targeting Oct4 and CIIA in H9 cells after transfection with control 
siRNA or CIIA siRNA on Day 3.
15
2. Effects of suppressed CIIA in human fibroblasts on reprogramming process
Previous studies have demonstrated that the first noticeable change during 
reprogramming of fibroblasts is their transformation into MET, the opposite of 
EMT.8 It is also known that CIIA induces EMT through a reduction in the 
abundance of E-cadherin and claudin-1.23 To identify whether downregulation of 
CIIA suppresses EMT, I performed transfection of CIIA siRNA into BJ fibroblasts 
and then qRT-PCR analysis targeting key transcripts related to the EMT process. It 
was confirmed that CIIA was knocked down initially by qRT-PCR (Fig. 2A). BJ 
fibroblasts transfected with CIIA siRNA showed epithelial-like morphological 
changes and also displayed decreased levels of EMT-related genes such as N-
cadherin, ZEB1, and Snail (Fig. 2B-D). At the same time, the expression level of 
TGF-βR2, an EMT regulatory factor, decreased following knockdown of CIIA (Fig. 
2E). Noticeably, suppression of CIIA in BJ fibroblasts elevated the expression of 
Klf4, which is an essential factor for reprogramming and an inducer of MET by 
direct activation of E-cadherin promoter. These results suggest that suppressed CIIA 
in human fibroblasts decreases EMT-related regulatory factors, which is the 
phenomenon occurring during the initial stage of reprogramming. This leads to the 
hypothesis that knockdown of CIIA might play a positive role on reprogramming.
To further analyze the role of CIIA, prolonged suppression of CIIA by four 
different CIIA shRNAs was performed in BJ fibroblasts. One week after 
transduction of lentivirus-producing CIIA shRNAs, it was confirmed by qRT-PCR 
analysis that CIIA had been knocked down (Fig. 3A). BJ fibroblasts expressing 
CIIA shRNAs showed decreased levels of EMT-related genes such as N-cadherin 
and Snail (Fig. 3B,C), and this was consistent with the result of transient 
knockdown experiments. Furthermore, to determine whether prolonged suppression 
of CIIA affects the late stage of reprogramming, I examined the expression of 
epigenetic modifiers involved in reprogramming. The induction of Sirt1, TET1 and
BRG1 that function as epigenetic modifiers during reprogramming was observed
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Figure 2. Downregulation of CIIA expression inhibits the expression of EMT-
related genes. (A-F) Transient down-regulation of CIIA expression inhibits the 
levels of EMT-related genes: N-cadherin, Snail, and ZEB1. qRT-PCR analysis for 
the indicated genes at Day 3 after transfection of scrambled control siRNA or CIIA 
siRNA in BJ fibroblasts. qRT-PCR chart values indicate expression of the specific 
gene normalized with β-actin.
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Figure 3. Suppressed CIIA expression enhances the levels of epigenetic modifiers 
and pluripotent genes. (A-J) Extended suppression of CIIA expression induces 
epigenetic modifiers (Sirt1, TET1, SWI/SNF complex) and pluripotent genes (Oct4, 
Nanog). qRT-PCR analysis for the indicated genes at day 7 after transduction using 
lentiviral vector pLenti-shRNA-GFP encoding four different shRNA for CIIA in BJ 
fibroblasts. qRT-PCR chart values indicate expression of the specific gene 
normalized with β-actin. (n=3, * P<0.05)
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following downregulation of prolonged CIIA in the stable CIIA-shRNA-expressing 
fibroblasts when measured with qRT-PCR (Fig. 3D-F). In previous reports, genome-
wide ChIP-chip and ChIP-seq experiments revealed enrichment of BRG1 at the 
promoter regions of genes that were also occupied by the pluripotency regulators 
Oct4, Sox2 and Nanog.27,28 BRG1 (also known as SMARCA4) is the catalytic 
subunit of the SWI/SNF complex, which is composed of BRG-associated factor 
(BAF) and polybromo BAF (PBAF). Therefore, I also performed qRT-PCR analysis 
targeting the remaining components of the esBAF complex,29 an embryonic stem 
cell chromatin-remodeling SWI/SNF complex. The expression level of BAF60a 
(SMARCD1) and BAF155 (SMARCC1), essential components of the esBAF 
SWI/SNF complex, were also increased in CIIA-reduced cells such as BRG1 (Fig. 
3G,H).  More importantly, BJ fibroblasts expressing shCIIA exhibited higher 
expression of pluripotent genes such as Oct4 and Nanog. Together, these 
observations suggest that CIIA in human somatic cells is important for the 
maintenance of cell characteristics and that suppression of CIIA expression has a 
positive effect on both the early and the late stages of the reprogramming process.
3. Knockdown of CIIA regulates epigenetic modifiers that favor reprogramming 
It was found that there is reciprocal expression of Sirt1 and CIIA in human 
fibroblast cells and in ESCs, i.e., CIIA is highly expressed in fibroblasts, but is quite 
low in ESCs. Conversely, Sirt1 is highly expressed in hESCs, whereas its 
expression is highly down-regulated in fibroblasts. Moreover, as shown in Figure 1, 
the level of CIIA is up-regulated during differentiation of hESCs. On the other hand, 
previous studies have shown that Sirt1 is known to be precisely down-regulated 
during hESC differentiation.30 Therefore, it was hypothesized that CIIA and Sirt1 
are mutually regulating. To test this hypothesis, I examined whether CIIA 
suppression affects Sirt1 expression and Sirt1 suppression affects CIIA expression
through specific siRNA transfection in BJ fibroblasts. Analysis by qRT-PCR reveal-
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Figure 4. CIIA regulates the level of Sirt1 that modulates expression of the 
SWI/SNF complex. (A, B) CIIA and Sirt1 are mutually regulating. Control siRNA, 
CIIA siRNA, or Sirt1 siRNA was transfected twice during 7 days in BJ fibroblasts, 
and mRNA levels of CIIA (A) and Sirt1 (B) were quantified by qRT-PCR assays. 
(C-F) H9 hESCs and Sirt inhibitor (TNV)-treated H9 hESCs were analyzed for 
indicated gene expression using qRT-PCR analysis. TNV was treated with 1 uM 
concentration for 12 hr. 
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-ed that Sirt1 expression was upregulated in CIIA siRNA expressing BJ fibroblasts, 
whereas CIIA expression was unregulated in Sirt1 siRNA expressing BJ fibroblasts 
(Fig. 4A, B). Sirt1 is a member of the sirtuin family of NAD+-dependent protein 
deacetylases. It is also known that this enzyme can directly interact and deacetylate 
a number of transcription factors and coregulators, leading to the positive and 
negative regulation of target gene expression. Furthermore, previous studies have 
shown that Sirt1 regulates chromatin-remodeling complexes such as the Clock-
Bmal13331 and SWI-SNF complexes.32 Therefore, I also confirmed that Sirt1, 
resulting from inhibited CIIA expression, regulates the SWI-SNF complex during 
cellular reprogramming. When the Sirt1 inhibitor Tenovin-6 (TNV) was treated in 
H9 hESCs to examine whether SWI-SNF complex subunits are linked with Sirt1 
activation, all of the subunits were decreased by TNV (Fig. 4C-E). I also confirmed 
the enhanced level of CIIA by TNV (Fig. 4F). Thus, these data suggest that CIIA 
regulates the level of Sirt1 that modulates the expression of the SWI/SNF complex. 
4. Down-regulation of CIIA opens epigenetic marks of key reprogramming factor
Cellular reprogramming requires erasing the somatic repressive chromatin 
and establishing a permissive chromatin state involving opening histones and 
changing the DNA structure.33 Thus, I analyzed the effect of suppressed CIIA 
expression on the transition of chromatin state because CIIA regulates the 
epigenetic modifiers, as shown in Figure 4. Initially, to examine whether suppressed 
CIIA enhances the open chromatin state, I assessed immunocytochemistry to detect 
trimethylation of histone3 at lysine 4 (H3K4me3). This epigenetic modification 
marks transcriptionally active genes.29,34 Immunocytochemistry showed that 
suppressed CIIA in shCIIA-expressing BJ fibroblasts increased H3K4me3 (Fig. 5A), 
whereas overexpressed CIIA in Dox-inducible GFP-CIIA-expressing BJ fibroblasts 
decreased (Fig. 5B). To further test that suppression of CIIA was required for
elevating the open chromatin state to induce the pluripotent state, chromatin immu-
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Figure 5. Knocking down of CIIA elevates permissive chromatin state on Oct4 
promoter region. (A) shcon or shCIIA expressing BJ fibroblasts were analyzed with 
immunochemistry analysis with specific antibody against H3me3K4. Graph 
showing the percentage of H3K4me3+ cells in BJ fibroblasts (right). (B) Chromatin 
immunoprecipitation (ChIP) assay in BJ fibroblasts transfected with control siRNA 
or CIIA siRNA. ChIP assay were performed using specific antibody against 
H3me3K4. Specific region of Oct4 promoter was amplified by qRT-PCR. 
A
B
C
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-noprecipitation followed by PCR analysis (ChIP-PCR) was performed to detect 
H3K4me3 on an Oct4 promoter region. CIIA-downregulated 293T cells showed 
elevated levels of H3K4me3 on an Oct4 promoter region (Fig. 5C). These results 
suggest the downregulation of CIIA enhanced H3K4me3 expression in the Oct4 
promoter region, preparing the permissive chromatin state for successful 
reprogramming.
5. Inhibition of CIIA in human fibroblasts promotes reprogramming efficiency
Since CIIA counteracts the reprogramming and suppression of CIIA is 
required for the maintenance of self-renewal and pluripotency in hESCs, I 
investigated whether knockdown of CIIA can enhance OSKM-induced 
reprogramming. To test this hypothesis, a combination of CIIA siRNA and OSKM 
episomal vectors was transfected in BJ fibroblasts. When CIIA expression was 
inhibited by siRNA, it exhibited a more efficient and faster reprogramming process 
than OKSM alone (Fig. 6B, C). Furthermore, prolonged suppression of CIIA by 
repeated transfection of CIIA siRNA showed more increased AP+ colonies than 
single-instance transfection (Fig. 6B, C).  On the other hand, to examine whether 
forced expression of CIIA with OSKM expression affects reprogramming, I 
established cells expressing GFP or GFP-CIIA by doxycycline (Dox) treatment, 
transfected OSKM in these cells, and treated them with Dox or DMSO. In contrast 
with the CIIA knockdown condition, AP+ colonies were very sparse in the CIIA 
overexpressed condition (Fig. 6B, C). These data showed that suppression of CIIA 
enhanced the efficiency of reprogramming, demonstrating that CIIA plays an 
important role in cellular reprogramming. Next, I also identified the axis of 
CIIA-Sirt1 in cellular reprogramming. When Sirt1, the counter-regulator of 
CIIA, was downregulated by siRNA transfection, the efficiency of 
reprogramming was greatly diminished, implying their reciprocal regulation
(Fig. 6B, C).
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Figure 6. Axis of CIIA-Sirt1 is crucial in the reprogramming process. (A) Schematic 
picture of reprogramming methods using GFP-CIIA, CIIA siRNA, and Sirt1 siRNA. 
(B) Quantification of AP+ colonies in episomal plasmid (OSKML)-transfected BJ 
fibroblasts (at Day 22). BJ fibroblasts were co-transfected with the indicated 
combination. (C) Representative AP-stained plates during reprogramming.
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IV. DISCUSSION
The present study has identified that CIIA constitutes a cellular and 
molecular barrier to reprogramming, with different expressions of CIIA between 
fibroblasts and pluripotent stem cells. First, short-term repression of CIIA 
negatively regulates EMT, which is known to be a major driving force in tumor 
formation and in embryonic development.35 Furthermore, the prolonged suppression 
of endogenous CIIA induces pluripotent genes and epigenetic modifiers that are 
abundant in PSCs, but are minimally expressed in fibroblasts. Finally, knocking 
down CIIA in combination with OSKM in fibroblasts could establish more ESC-
like colonies than with just OSKM alone.
As previous investigators have reported, CIIA identical to VPS28 playing 
an endocytotic role,36 functions as an apoptotic protein.21 In addition, CIIA 
physically associates with SOS1 and promotes the SOS1-mediated activation of 
Rac1.25 It also suppresses the SOS1-mediated activation of Ras37 that provides 
instructions for cell growth and development. This study demonstrated a new role of 
CIIA in cellular reprogramming. Thus, this study also newly revealed that the 
knockdown of CIIA in fibroblasts exhibits more efficient reprogramming, forming 
more iPSC colonies than OSKM alone.
Another interesting link here is that CIIA modulates Sirt1 expression, and 
this link controls a significant aspect of reprogramming. It has been observed that 
Sirt1 accelerates iPSC reprogramming via the miR-34a and p53 pathways,38
consistent with prior evidence that Sirtuin mediates p53 in cancer.39 Furthermore, 
Sirt1 modifies histones and DNA in epigenetic regulation, as well as interactions 
with a broad range of transcription factors.40 Sirt1 has been shown to regulate 
chromatin-remodeling complexes such as the Clock-Bmal131 and SWI-SNF 
complexes.32 This study also demonstrated that Sirt1, resulting from inhibited CIIA 
expression, regulates the SWI/SNF complex during cellular reprogramming. BRG1 
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of bona fide subunits in the SWI/SNF complex, including BAF complex 
components, has been observed to regulate self-renewal and pluripotency.41 Prior 
studies also show that the BAF complex can replace cmyc,41 one of the 
reprogramming factors, and open chromatin structures on binding sites of key 
pluripotent factors. Therefore, these results suggest that enhanced Sirt1, regulating 
epigenetic modification, potentially promotes the SWI/SNF complex, and that this 
chromatin-remodeling complex controls the H3K4me3 level on the Oct4 promoter 
region. 
The reprogramming of human fibroblasts using small molecules such as 
siRNA, miRNA, and chemicals may be especially challenging for the formation of 
safe human iPSCs.42-45 However, the replacement of Oct4 by small molecules has 
been one major issue to overcome. This research has shown that the knockdown of 
CIIA increased Oct4 expression, but it was not sufficient to fully turn on the 
endogenous Oct4 expression. Therefore, this study cannot preclude the possibility 
that siRNA of CIIA may replace Oct4, one of the key Yamanaka factors. 
These data showed that CIIA is a hurdle to be surmounted during cellular 
reprogramming. It is important to note, however, that the suppression of CIIA 
would stimulate Oct4 through the modulation of epigenetic modifiers. Further 
observations are needed to substitute small molecules for reprogramming factors, 
but these findings suggest the possibility of forming safer and more efficient iPSCs.
In addition, our understanding of the mechanism underlying cellular reprogramming 
through this study suggests strategies to improve modeling and curing disease, and 
advances our insight into the regulation of pluripotency.
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V. CONCLUSION
To summarize, this study has presented the finding that CIIA is closely 
involved in cell fate change, negatively regulating the transcriptional network and 
chromatin configuration. Decreased CIIA gene expression not only blocks EMT in 
the initial reprogramming stage, but also remodels histone modification by 
enhancing the active H3K4me3 levels on the Oct4 promoter region. In this process, 
a chromatin remodeling complex, SWI/SNF, is promoted by up-regulated Sirt1 
expression, and then activates the H3K4me3 structure, opening the Oct4 promoter 
region. This transcriptional activity of Oct4, one of the key stemness factors, could 
allow more iPSC candidates to be fully reprogrammed while turning on the other 
pluripotent genes such as Sox2, klf4, cmyc and Nanog. In conclusion, suppressed 
CIIA expression is crucial to form more iPSC colonies, conquering reprogramming 
barriers.
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ABSTRACT (in korean)
세포리프로그래밍에서 CIIA 유전자의 역할
<지도교수 김 동 욱>
연세대학교 대학원 의과학과
지  은  현
역분화 기술은 배아를 사용하지 않고 환자로부터 채취한 체세포
에서 전분화능을 지닌 유도만능줄기세포를 생성하는 것으로 재생의학에
서 매우 각광받고 있는 분야이다. 그러나 임상 적용을 위한 안정성 확보
와 현저히 낮은 역분화 효율 문제는 여전히 개선이 필요한 부분이다. 본
연구에서는 CIIA 유전자의 발현이 세포리프로그래밍시 낮은 역분화 효율
을 일으키는 걸림돌 중 하나임을 밝혔다. 먼저, siRNA, shRNA 기술을 이
용하여 CIIA의 발현량을 낮추었을 때 상피중간엽세포이행관련 유전자 발
현이 줄어드는, 즉 세포리프로그래밍 초기에 관찰할 수 있는 특징이 보일
뿐 아니라 후생학적 변이와 관련된 유전자의 발현 변화 또한 관찰 할 수
있었다. 이는 CIIA를 단독으로 감소시키는 것만으로도 세포의 특성을 변
화시킬 수 있는 것을 의미한다. 그리고 분자적 수준에서의 실험들을 통해
CIIA가 Sirt1(히스톤변형인자)발현을 조절함으로써 세포리프로그래밍을
저해함을 밝혔다. 마지막으로 CIIA발현을 감소시킨 체세포에서 OSKM(역
분화줄기세포 생성 유전자)의 도입은 OSKM만 도입했을 때에 비해 더
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많은 배아줄기세포유사 역분화줄기세포를 생성함을 관찰할 수 있었다. 이
러한 연구 결과를 통해 세포리프로그래밍에서 역할을 하는 CIIA 유전자
의 새로운 기능을 알 수 있었다. 또한 이를 통해 리프로그래밍에서 일어
나는 현상을 더 이해함으로써 역분화줄기세포 생성효율 문제점을 해결할
만한 새로운 방법을 제시했다.
핵심되는 말: 역분화 줄기세포, CIIA유전자, 상피중간엽세포이행(EMT), 
후생학적변이, 세포리프로그래밍
